Copaxone subcutaneous injection 20 mg syringe, manufactured by Takeda Teva Pharma, contains glatiramer acetate. This immunomodulator is used to treat relapsing forms of multiple sclerosis (MS) in adults. This product is a 20 mg syringe with YJ code 3999440G1024 and is specified as 300mg 2mL per kit.
Copaxone subcutaneous injection 20 mg syringe
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).
